Determination of platinum originating from carboplatin in canine sebum and cerumen by inductively coupled plasma mass spectrometry.

T. Janssens, E.E.M. Brouwers, J.P. de Vos, J.H. Schellens, J.H. Beijnen

Research output: Contribution to journalArticleAcademicpeer-review


We present highly sensitive, reliable methods for the determination of platinum originating from carboplatin in canine sebum and cerumen. The methods are based on the measurement of platinum by inductively coupled plasma mass spectrometry and allow quantification of 0.15 pg platinum per cm(2) body surface in canine sebum and of 7.50 pg platinum per sampled ear canal. The sample pretreatment procedure involved extraction of wipe samples followed by dilution with appropriate diluents. The performance of the methods, in terms of accuracy and precision, fulfilled the most recent FDA guidelines for bioanalytical method validation. Validated ranges of quantification were 15.0-1.00 x 10 ng L(1) for platinum in canine sebum extraction solution (corresponding to 15.0 pg per wipe sample or 0.15 pgcm(2)) and 7.50-1.00 x 10 ng L(1) for platinum in canine cerumen extraction solution (corresponding to 7.50 pg per sampled external acoustic meatus). Canine matrices may not always be obtained in sufficient quantities. Therefore, we also confirmed the legitimacy of the application of human matrix samples for the preparation of calibration standards and quality control samples as alternatives, to be used in future clinical studies. The assays are used to support human biomonitoring studies and pharmacokinetic oncology studies in pet dogs treated with carboplatin.
Original languageUndefined/Unknown
Pages (from-to)395-400
Number of pages6
JournalJournal of Pharmaceutical and Biomedical Analysis
Issue number2
Publication statusPublished - 2011

Cite this